{
    "hands_on_practices": [
        {
            "introduction": "A hallmark of behavioral variant frontotemporal dementia (bvFTD) is a profound and early decline in executive functions. This practice provides a direct method for quantifying this deficit using data from standard neuropsychological tests. By converting raw test scores into standardized $z$-scores, you will practice a fundamental skill for interpreting clinical data and learn how to create a composite index to gauge the overall severity of impairment .",
            "id": "4480967",
            "problem": "A clinician is evaluating a $58$-year-old patient with suspected behavioral variant frontotemporal dementia (bvFTD) for executive dysfunction using two canonical frontal-executive measures: the Trail Making Test Part B (TMT-B) and the Stroop Color-Word interference condition from the Stroop Color-Word Test. The patient’s raw scores are: TMT-B completion time of $180$ seconds and Stroop interference commission errors of $12$. Assume that higher raw values on both measures indicate worse performance. Normative data for an age- and education-matched cohort are modeled as approximately normally distributed with the following parameters: for TMT-B, mean $\\mu_{B} = 75$ seconds and standard deviation $\\sigma_{B} = 30$ seconds; for Stroop interference errors, mean $\\mu_{S} = 5$ and standard deviation $\\sigma_{S} = 3$. Using the foundational psychometric definition of standardization to convert each raw score to a standardized score relative to its normative distribution, and treating the two standardized dimensions as independent, construct a composite executive dysfunction index by taking the Euclidean norm of the two standardized scores. Then, provide a principled interpretation of the severity of dysfunction in the context of frontotemporal dementia and related syndromes compared to typical Alzheimer disease (AD) patterns. Report as your final answer only the composite index value as a single real number without units, rounded to three significant figures.",
            "solution": "The problem is valid as it is scientifically grounded, well-posed, and objective. It provides a complete set of data and a clear, formalizable task based on established principles of psychometric assessment in neurology.\n\nThe first step is to standardize the patient's raw scores on the Trail Making Test Part B (TMT-B) and the Stroop Color-Word interference task. Standardization converts a raw score into a standard score (z-score), which represents the number of standard deviations the raw score is from the mean of the normative sample. The formula for a z-score is:\n$$z = \\frac{x - \\mu}{\\sigma}$$\nwhere $x$ is the patient's raw score, $\\mu$ is the mean of the normative sample, and $\\sigma$ is the standard deviation of the normative sample. For both tests, a higher raw score indicates worse performance, so a positive z-score will indicate performance that is worse than the average.\n\nFor the TMT-B, the patient's raw score is $x_B = 180$ seconds. The normative parameters are a mean of $\\mu_B = 75$ seconds and a standard deviation of $\\sigma_B = 30$ seconds. The standardized score, $z_B$, is therefore:\n$$z_B = \\frac{x_B - \\mu_B}{\\sigma_B} = \\frac{180 - 75}{30} = \\frac{105}{30} = 3.5$$\n\nFor the Stroop interference errors, the patient's raw score is $x_S = 12$ errors. The normative parameters are a mean of $\\mu_S = 5$ errors and a standard deviation of $\\sigma_S = 3$ errors. The standardized score, $z_S$, is:\n$$z_S = \\frac{x_S - \\mu_S}{\\sigma_S} = \\frac{12 - 5}{3} = \\frac{7}{3}$$\n\nThe problem requires constructing a composite executive dysfunction index, $I$, by taking the Euclidean norm of the two standardized scores, $z_B$ and $z_S$. This is equivalent to finding the magnitude of a vector in a two-dimensional space with coordinates $(z_B, z_S)$.\n$$I = \\sqrt{z_B^2 + z_S^2}$$\nSubstituting the calculated values:\n$$I = \\sqrt{(3.5)^2 + \\left(\\frac{7}{3}\\right)^2} = \\sqrt{\\left(\\frac{7}{2}\\right)^2 + \\left(\\frac{7}{3}\\right)^2}$$\n$$I = \\sqrt{\\frac{49}{4} + \\frac{49}{9}} = \\sqrt{49 \\left(\\frac{1}{4} + \\frac{1}{9}\\right)} = \\sqrt{49 \\left(\\frac{9+4}{36}\\right)} = \\sqrt{49 \\cdot \\frac{13}{36}}$$\n$$I = \\frac{\\sqrt{49}\\sqrt{13}}{\\sqrt{36}} = \\frac{7\\sqrt{13}}{6}$$\nTo obtain the final numerical value, we compute the expression and round to three significant figures:\n$$I \\approx \\frac{7 \\times 3.60555}{6} \\approx 4.206476$$\nRounding to three significant figures, the composite index is $I \\approx 4.21$.\n\nA principled interpretation of this result in the context of frontotemporal dementia (FTD) versus Alzheimer disease (AD) is as follows. The calculated standardized scores, $z_B = 3.5$ and $z_S \\approx 2.33$, indicate performance that is profoundly impaired, falling $3.5$ and approximately $2.33$ standard deviations below the mean of the age- and education-matched normative group. These scores are well within the range typically considered severely to profoundly impaired in clinical neuropsychology (where $|z| > 2$ is often a threshold for severe impairment).\n\nThe tests themselves, TMT-B and Stroop interference, are canonical measures of executive functions, which include cognitive flexibility, set-shifting, response inhibition, and processing speed. The composite index, $I \\approx 4.21$, quantifies the overall magnitude of this executive deficit in a single metric. A value of this magnitude reflects a catastrophic failure of frontal-executive systems.\n\nThis specific cognitive profile is the hallmark of behavioral variant frontotemporal dementia (bvFTD). In bvFTD, neurodegeneration preferentially targets the frontal and anterior temporal lobes, which are the primary neural substrates for executive functions and social-emotional regulation. Consequently, the earliest and most prominent clinical features of bvFTD are profound executive dysfunction and changes in behavior and personality, often with relative sparing of memory and visuospatial functions in the early stages.\n\nIn contrast, the typical presentation of Alzheimer disease (AD) involves a primary impairment of episodic memory, particularly delayed recall. This is because AD pathology typically begins in the medial temporal lobes, including the hippocampus, which are critical for memory consolidation. While patients with AD eventually develop executive dysfunction as the pathology spreads to frontal cortices, it is a later feature and is usually less severe than the memory deficit in the initial stages of the disease. Therefore, a patient in the early stages of typical AD would be expected to have a much more impaired score on a test of delayed memory recall and a comparatively milder deficit on tests of executive function.\n\nIn summary, the patient's performance, characterized by a massive deficit in executive function as quantified by the composite index of $I \\approx 4.21$, provides strong quantitative evidence that aligns with the classic cognitive profile of bvFTD and distinguishes it from the typical amnestic presentation of AD.",
            "answer": "$$\\boxed{4.21}$$"
        },
        {
            "introduction": "Following clinical assessment, neuroimaging biomarkers are crucial for the differential diagnosis of dementia. This exercise simulates the interpretation of a Fluorodeoxyglucose Positron Emission Tomography (FDG-PET) scan, a key tool that reveals patterns of brain metabolism. You will learn to apply a quantitative decision rule to differentiate the characteristic anterior hypometabolism of FTD from the posterior hypometabolism typical of Alzheimer's disease .",
            "id": "4481022",
            "problem": "A patient with progressive socioemotional blunting and semantic deficits undergoes Fluorodeoxyglucose Positron Emission Tomography (FDG-PET) to assess regional cerebral glucose metabolism. The imaging report provides a Standardized Uptake Value Ratio (SUVR), defined as $ \\mathrm{SUVR} = \\dfrac{\\mathrm{SUV}_{\\text{region}}}{\\mathrm{SUV}_{\\text{reference}}} $, for two regions: anterior temporal lobes and posterior cingulate cortex. The measured values are $ \\mathrm{SUVR}_{\\text{anterior temporal}} = 0.75 $ and $ \\mathrm{SUVR}_{\\text{posterior cingulate}} = 1.05 $, using a disease-sparing reference region.\n\nYou are asked to determine whether the FDG-PET pattern supports frontotemporal dementia (FTD) over Alzheimer’s disease (AD), given a decision rule based on a cutoff SUVR difference of $ 0.20 $. The decision rule is defined on the principle that anterior temporal and frontal hypometabolism with relative sparing of posterior cingulate metabolism favors FTD, whereas posterior cingulate hypometabolism with temporoparietal involvement favors AD. Use the following foundational bases:\n\n- FDG-PET reflects neuronal synaptic activity via glucose utilization; lower metabolism manifests as reduced $ \\mathrm{SUVR} $ in disease-affected regions.\n- In AD, early and characteristic hypometabolism involves posterior cingulate and precuneus, often with temporoparietal spread, whereas frontal and anterior temporal regions are comparatively less affected early.\n- In FTD, frontal and anterior temporal hypometabolism is typical, with relative preservation of posterior cingulate metabolism.\n\nCompute the relevant $ \\mathrm{SUVR} $ difference and apply the given cutoff to decide which diagnosis is better supported by the pattern.\n\nWhich option is most appropriate?\n\nA. The FDG-PET pattern supports frontotemporal dementia over Alzheimer’s disease.\n\nB. The FDG-PET pattern supports Alzheimer’s disease over frontotemporal dementia.\n\nC. The FDG-PET pattern is equivocal because the $ \\mathrm{SUVR} $ difference does not exceed $ 0.20 $.\n\nD. The FDG-PET pattern suggests a posterior cortical atrophy variant due to posterior cingulate hypometabolism.",
            "solution": "The problem statement will first be validated for scientific soundness, clarity, and completeness.\n\n**Step 1: Extract Givens**\n- Patient presentation: Progressive socioemotional blunting and semantic deficits.\n- Imaging modality: Fluorodeoxyglucose Positron Emission Tomography (FDG-PET).\n- Definition of Standardized Uptake Value Ratio (SUVR): $ \\mathrm{SUVR} = \\dfrac{\\mathrm{SUV}_{\\text{region}}}{\\mathrm{SUV}_{\\text{reference}}} $.\n- Measured values: $ \\mathrm{SUVR}_{\\text{anterior temporal}} = 0.75 $ and $ \\mathrm{SUVR}_{\\text{posterior cingulate}} = 1.05 $.\n- Reference region: A disease-sparing reference region is used.\n- Decision rule: A cutoff SUVR difference of $ 0.20 $ is used to decide between frontotemporal dementia (FTD) and Alzheimer’s disease (AD).\n- Foundational principles:\n    1.  FDG-PET measures glucose utilization, which reflects synaptic activity. Lower metabolism (hypometabolism) results in a reduced $ \\mathrm{SUVR} $.\n    2.  AD is characterized by early hypometabolism in the posterior cingulate/precuneus and temporoparietal regions.\n    3.  FTD is characterized by hypometabolism in frontal and anterior temporal regions, with relative sparing of the posterior cingulate.\n\n**Step 2: Validate Using Extracted Givens**\nThe problem is assessed against the required criteria.\n- **Scientifically Grounded**: The problem is well-grounded in established principles of neurology and nuclear medicine. The clinical symptoms described are classic for FTD syndromes. The use of FDG-PET, SUVR quantification, and the described metabolic patterns for AD and FTD are standard in the differential diagnosis of dementia. The SUVR values provided are realistic.\n- **Well-Posed**: The problem is well-posed. It provides all necessary quantitative data ($ \\mathrm{SUVR} $ values), a clear definition for the key metric, a specific decision rule (cutoff value), and a distinct question that can be answered by applying the rule to the data.\n- **Objective**: The problem is stated in precise, objective, and clinical terms. It relies on quantitative measurements and a pre-defined rule for interpretation, removing subjectivity.\n\nThe problem statement does not violate any of the invalidity criteria. It is scientifically sound, well-posed, objective, complete, and realistic.\n\n**Step 3: Verdict and Action**\nThe problem statement is valid. A full solution will be derived.\n\n**Derivation of the Solution**\nThe task is to determine whether the given FDG-PET pattern better supports a diagnosis of FTD or AD. This is achieved by analyzing the regional glucose metabolism as indicated by the SUVR values, in accordance with the provided principles and decision rule.\n\n1.  **Analyze the Regional Metabolism Pattern**:\n    - The foundational principles state that a reduced $ \\mathrm{SUVR} $ indicates hypometabolism.\n    - The anterior temporal lobes have an $ \\mathrm{SUVR} $ of $ 0.75 $. This value is less than $ 1.0 $, indicating significant hypometabolism relative to the disease-sparing reference region. This finding is characteristic of FTD.\n    - The posterior cingulate cortex has an $ \\mathrm{SUVR} $ of $ 1.05 $. This value is slightly above $ 1.0 $, indicating that metabolism in this region is preserved, or even slightly elevated relative to the reference. Sparing of the posterior cingulate cortex is characteristic of FTD, whereas hypometabolism in this region is a hallmark of AD.\n    - The qualitative pattern of anterior temporal hypometabolism ($ \\mathrm{SUVR} = 0.75 $) with preservation of the posterior cingulate cortex ($ \\mathrm{SUVR} = 1.05 $) is strongly suggestive of FTD.\n\n2.  **Apply the Quantitative Decision Rule**:\n    - The problem provides a decision rule based on a \"cutoff SUVR difference of $ 0.20 $\". The relevant difference is the one that contrasts the regions typically affected in AD versus FTD. This would be the difference between the posterior cingulate $ \\mathrm{SUVR} $ and the anterior temporal $ \\mathrm{SUVR} $.\n    - Let us define this difference as $ \\Delta\\mathrm{SUVR} $.\n    $$ \\Delta\\mathrm{SUVR} = \\mathrm{SUVR}_{\\text{posterior cingulate}} - \\mathrm{SUVR}_{\\text{anterior temporal}} $$\n    - Substituting the given values:\n    $$ \\Delta\\mathrm{SUVR} = 1.05 - 0.75 = 0.30 $$\n    - The decision rule requires comparing this difference to the cutoff value of $ 0.20 $.\n    $$ 0.30 > 0.20 $$\n    - The calculated difference of $ 0.30 $ exceeds the specified cutoff of $ 0.20 $. A large positive difference indicates that the posterior cingulate metabolism is substantially higher than the anterior temporal metabolism, which is the signature pattern of FTD. Since the difference surpasses the threshold, the rule confirms that the pattern supports FTD over AD.\n\n**Evaluation of Options**\n\n**A. The FDG-PET pattern supports frontotemporal dementia over Alzheimer’s disease.**\nThis statement aligns perfectly with our analysis. The qualitative pattern (anterior hypometabolism, posterior sparing) and the quantitative analysis ($ \\Delta\\mathrm{SUVR} = 0.30 > 0.20 $) both strongly support a diagnosis of FTD over AD.\n**Verdict: Correct.**\n\n**B. The FDG-PET pattern supports Alzheimer’s disease over frontotemporal dementia.**\nThis statement is contrary to the evidence. An AD pattern would feature a low $ \\mathrm{SUVR}_{\\text{posterior cingulate}} $. The data show the opposite ($ \\mathrm{SUVR}_{\\text{posterior cingulate}} = 1.05 $), indicating preservation.\n**Verdict: Incorrect.**\n\n**C. The FDG-PET pattern is equivocal because the $ \\mathrm{SUVR} $ difference does not exceed $ 0.20 $.**\nThis statement's premise is factually incorrect. The calculated $ \\mathrm{SUVR} $ difference is $ 0.30 $, which *does* exceed $ 0.20 $. Therefore, the pattern is not equivocal by the given rule.\n**Verdict: Incorrect.**\n\n**D. The FDG-PET pattern suggests a posterior cortical atrophy variant due to posterior cingulate hypometabolism.**\nPosterior cortical atrophy (PCA) is a visual variant of AD characterized by primary hypometabolism in the occipital cortex. The rationale provided in the option is \"due to posterior cingulate hypometabolism\". The data show a preserved posterior cingulate ($ \\mathrm{SUVR} = 1.05 $), not hypometabolism. The premise is false.\n**Verdict: Incorrect.**",
            "answer": "$$\\boxed{A}$$"
        },
        {
            "introduction": "Cognitive neuropsychology provides powerful logical frameworks for linking specific cognitive functions to distinct neural systems. In this advanced exercise, you will apply the principle of double dissociation, using detailed data from two contrasting patient cases to build a robust argument for the separate neural substrates underlying social cognition (impaired in FTD) and episodic memory (impaired in Alzheimer's disease). This practice will sharpen your ability to synthesize behavioral and anatomical evidence to localize cognitive deficits .",
            "id": "4481013",
            "problem": "A clinical scientist is evaluating two patients to determine whether their deficits implicate primarily frontotemporal networks or the hippocampal formation. The reasoning will rely on the cognitive neuropsychology method of double dissociation and established neuroanatomical-functional associations. Established facts for the base of reasoning include: the hippocampal formation is necessary for episodic memory encoding and consolidation; frontotemporal salience and semantic appraisal networks anchored in anterior insula, anterior cingulate cortex, orbitofrontal cortex, and temporal pole mediate social cognition constructs such as Theory of Mind (ToM), empathic processing, and social norm adherence; double dissociation is defined as one case in which function $A$ is impaired and function $B$ is intact, paired with another case in which function $B$ is impaired and function $A$ is intact, thereby supporting relative independence and distinct neural substrates.\n\nPatient X is a $68$-year-old individual with progressive changes in behavior, including reduced empathy and inappropriate social comments. Neuropsychological testing shows normal episodic memory but impaired social cognition:\n- Rey Auditory Verbal Learning Test (RAVLT) delayed free recall $z_{\\text{RAVLT}}=+0.3$.\n- Theory of Mind (ToM) composite $z_{\\text{ToM}}=-2.4$.\n- Reading the Mind in the Eyes test $z_{\\text{Eyes}}=-2.1$.\n- Face emotion recognition $z_{\\text{FER}}=-2.0$.\n- Digit Span forward $z_{\\text{DSF}}=0.0$ and backward $z_{\\text{DSB}}=-0.4$.\n- Mini-Mental State Examination (MMSE) $z_{\\text{MMSE}}=-0.2$.\nMagnetic Resonance Imaging (MRI) shows reduced cortical thickness in anterior insula, orbitofrontal cortex, and temporal pole; hippocampal volumes are within age-adjusted norms: anterior insula volume $V_{\\text{AI}}$ at the $15$th percentile, orbitofrontal cortex volume $V_{\\text{OFC}}$ at the $12$th percentile, hippocampal volume $V_{\\text{HIP}}$ at the $55$th percentile.\n\nPatient Y is a $66$-year-old individual with progressive episodic amnesia. Social cognition tasks are intact while episodic memory is impaired:\n- RAVLT delayed free recall $z_{\\text{RAVLT}}=-2.7$.\n- ToM composite $z_{\\text{ToM}}=-0.1$.\n- Eyes test $z_{\\text{Eyes}}=+0.2$.\n- Face emotion recognition $z_{\\text{FER}}=+0.1$.\n- Digit Span forward $z_{\\text{DSF}}=-0.1$ and backward $z_{\\text{DSB}}=-0.2$.\n- MMSE $z_{\\text{MMSE}}=-0.3$.\nMRI shows bilateral hippocampal sclerosis with $V_{\\text{HIP}}$ at the $5$th percentile; anterior insula and orbitofrontal cortex volumes are within age norms: $V_{\\text{AI}}$ at the $58$th percentile, $V_{\\text{OFC}}$ at the $60$th percentile.\n\nIn a reference cohort of $n=40$ older adults with mixed degenerative etiologies matched for global disease severity (composite severity scaler $D$; Patient X $D=1.2$, Patient Y $D=1.2$), the following associations are observed controlling for age and MMSE via partial correlations: $r_{p}(V_{\\text{HIP}}, z_{\\text{RAVLT}})=+0.55$, $r_{p}(V_{\\text{AI}}, z_{\\text{ToM}})=+0.60$, with cross-domain associations near zero $r_{p}(V_{\\text{HIP}}, z_{\\text{ToM}})=+0.08$, $r_{p}(V_{\\text{AI}}, z_{\\text{RAVLT}})=+0.05$.\n\nUsing double-dissociation reasoning and the provided data, select all statements that are justified.\n\nA. The pair of cases establishes a double dissociation between social cognition and episodic memory, supporting relative independence of these functions and suggesting that Patient X’s primary pathology lies in frontotemporal salience and semantic appraisal networks rather than the hippocampal formation.\n\nB. The data rule out any contribution of the hippocampal formation to social cognition in healthy adults.\n\nC. The profile in Patient X is most parsimoniously explained by a single-domain attentional deficit; since attention $z$-scores are near normal, the deficits likely reflect general factors rather than distinct neural systems.\n\nD. The complementary anatomical and behavioral pattern across patients, together with independent volume–performance associations in the cohort, support network-level localization: anterior insula and orbitofrontal cortex for social cognition and hippocampal formation for episodic memory.\n\nE. The intact episodic memory in Patient X proves that behavioral variant Frontotemporal Dementia (bvFTD) never impairs episodic memory at any disease stage.",
            "solution": "The problem statement is evaluated for validity prior to attempting a solution.\n\n### Step 1: Extract Givens\n\n*   **Established Fact 1**: The hippocampal formation is necessary for episodic memory encoding and consolidation.\n*   **Established Fact 2**: Frontotemporal salience and semantic appraisal networks, including the anterior insula, anterior cingulate cortex, orbitofrontal cortex, and temporal pole, mediate social cognition constructs such as Theory of Mind (ToM), empathic processing, and social norm adherence.\n*   **Definition**: A double dissociation is defined as a pair of cases where in one case, function $A$ is impaired and function $B$ is intact, and in the second case, function $B$ is impaired and function $A$ is intact. This supports the relative independence of the functions and their distinct neural substrates.\n*   **Patient X**: A $68$-year-old individual with progressive changes in behavior (reduced empathy, inappropriate social comments).\n    *   Neuropsychology:\n        *   Episodic memory: Rey Auditory Verbal Learning Test (RAVLT) delayed free recall $z_{\\text{RAVLT}}=+0.3$ (intact).\n        *   Social cognition: Theory of Mind (ToM) composite $z_{\\text{ToM}}=-2.4$ (impaired), Reading the Mind in the Eyes test $z_{\\text{Eyes}}=-2.1$ (impaired), Face emotion recognition $z_{\\text{FER}}=-2.0$ (impaired).\n        *   Other tests: Digit Span forward $z_{\\text{DSF}}=0.0$, Digit Span backward $z_{\\text{DSB}}=-0.4$, Mini-Mental State Examination (MMSE) $z_{\\text{MMSE}}=-0.2$.\n    *   MRI:\n        *   Reduced cortical thickness in anterior insula, orbitofrontal cortex, and temporal pole.\n        *   Anterior insula volume $V_{\\text{AI}}$ at the $15$th percentile.\n        *   Orbitofrontal cortex volume $V_{\\text{OFC}}$ at the $12$th percentile.\n        *   Hippocampal volume $V_{\\text{HIP}}$ at the $55$th percentile.\n    *   Disease Severity: Composite severity scaler $D=1.2$.\n*   **Patient Y**: A $66$-year-old individual with progressive episodic amnesia.\n    *   Neuropsychology:\n        *   Episodic memory: RAVLT delayed free recall $z_{\\text{RAVLT}}=-2.7$ (impaired).\n        *   Social cognition: ToM composite $z_{\\text{ToM}}=-0.1$ (intact), Eyes test $z_{\\text{Eyes}}=+0.2$ (intact), Face emotion recognition $z_{\\text{FER}}=+0.1$ (intact).\n        *   Other tests: Digit Span forward $z_{\\text{DSF}}=-0.1$, Digit Span backward $z_{\\text{DSB}}=-0.2$, MMSE $z_{\\text{MMSE}}=-0.3$.\n    *   MRI:\n        *   Bilateral hippocampal sclerosis with $V_{\\text{HIP}}$ at the $5$th percentile.\n        *   Anterior insula volume $V_{\\text{AI}}$ at the $58$th percentile.\n        *   Orbitofrontal cortex volume $V_{\\text{OFC}}$ at the $60$th percentile.\n    *   Disease Severity: Composite severity scaler $D=1.2$.\n*   **Reference Cohort**: $n=40$ older adults with mixed degenerative etiologies, matched for global disease severity $D$.\n    *   Partial correlations controlling for age and MMSE:\n        *   $r_{p}(V_{\\text{HIP}}, z_{\\text{RAVLT}})=+0.55$.\n        *   $r_{p}(V_{\\text{AI}}, z_{\\text{ToM}})=+0.60$.\n        *   $r_{p}(V_{\\text{HIP}}, z_{\\text{ToM}})=+0.08$.\n        *   $r_{p}(V_{\\text{AI}}, z_{\\text{RAVLT}})=+0.05$.\n*   **Question**: Select all justified statements using double-dissociation reasoning and the provided data.\n\n### Step 2: Validate Using Extracted Givens\n\nThe problem statement is scientifically sound, well-posed, and objective.\n1.  **Scientific Grounding**: The problem is grounded in established principles of cognitive neuropsychology, neurology, and neuroanatomy. The concepts of double dissociation, the roles of the hippocampus in memory and frontotemporal networks in social cognition, and the use of $z$-scores, volumetric MRI, and correlational analyses are all standard in the field. The presented patient profiles are classic representations of behavioral variant frontotemporal dementia (like Patient X) and an amnestic syndrome of the hippocampal type (like Patient Y).\n2.  **Completeness and Consistency**: The problem is self-contained and provides all necessary data to evaluate the options. The behavioral data (neuropsychology scores), anatomical data (MRI volumes), and cohort-level statistical data (correlations) are internally consistent and mutually reinforcing. For example, Patient X's social cognition deficits align with their frontotemporal atrophy, and Patient Y's memory deficits align with their hippocampal atrophy. The matching of patients on a disease severity scaler ($D=1.2$) is a methodologically sound control.\n3.  **Clarity and Objectivity**: The problem is stated using precise, quantitative, and objective language (e.g., $z$-scores, percentiles, correlation coefficients). There is no ambiguity in the definitions or data provided.\n\n### Step 3: Verdict and Action\n\nThe problem statement is **valid**. The analysis can proceed.\n\n### Solution Derivation\n\nThe core task is to apply the principle of double dissociation to the two patient cases and integrate the findings with the provided cohort data.\n\nLet us define the functions and neural substrates:\n*   Function $A$: Social cognition (measured by ToM, Eyes test, FER).\n*   Function $B$: Episodic memory (measured by RAVLT delayed recall).\n*   Neural Substrate $A$: Frontotemporal networks (anterior insula, orbitofrontal cortex).\n*   Neural Substrate $B$: Hippocampal formation.\n\nAnalysis of Patient X:\n*   Function $A$ (Social cognition) is significantly impaired, with $z$-scores of $-2.4$, $-2.1$, and $-2.0$. A $z$-score below $-1.5$ is typically considered clinically significant.\n*   Function $B$ (Episodic memory) is intact, with a $z$-score of $+0.3$.\n*   Neural Substrate $A$ (Frontotemporal networks) shows atrophy, with volumes at the $15$th and $12$th percentiles.\n*   Neural Substrate $B$ (Hippocampal formation) is structurally normal, with volume at the $55$th percentile.\n*   Conclusion for Patient X: There is a dissociation where social cognition is impaired while episodic memory is spared, which corresponds to damage in frontotemporal networks with a spared hippocampus.\n\nAnalysis of Patient Y:\n*   Function $A$ (Social cognition) is intact, with $z$-scores of $-0.1$, $+0.2$, and $+0.1$.\n*   Function $B$ (Episodic memory) is significantly impaired, with a $z$-score of $-2.7$.\n*   Neural Substrate $A$ (Frontotemporal networks) is structurally normal, with volumes at the $58$th and $60$th percentiles.\n*   Neural Substrate $B$ (Hippocampal formation) shows significant atrophy, with volume at the $5$th percentile.\n*   Conclusion for Patient Y: There is a complementary dissociation where episodic memory is impaired while social cognition is spared, which corresponds to damage in the hippocampus with spared frontotemporal networks.\n\nDouble Dissociation:\nPairing Patient X (impaired $A$, intact $B$) with Patient Y (intact $A$, impaired $B$) fulfills the an-atomoclinical definition of a double dissociation. According to the problem's own premise, this supports the conclusion that social cognition and episodic memory are relatively independent functions subserved by distinct neural substrates (frontotemporal networks and hippocampus, respectively).\n\nCohort Data Analysis:\nThe partial correlation data from the reference cohort provide convergent, group-level evidence.\n*   The strong, positive correlations within domains ($r_{p}(V_{\\text{HIP}}, z_{\\text{RAVLT}})=+0.55$ and $r_{p}(V_{\\text{AI}}, z_{\\text{ToM}})=+0.60$) confirm the specific structure-function relationships. Larger volumes are associated with better performance on the corresponding cognitive task.\n*   The near-zero cross-domain correlations ($r_{p}(V_{\\text{HIP}}, z_{\\text{ToM}})=+0.08$ and $r_{p}(V_{\\text{AI}}, z_{\\text{RAVLT}})=+0.05$) demonstrate the specificity of these relationships, powerfully arguing against a general \"brain health\" or \"disease severity\" confound.\n\n### Option-by-Option Analysis\n\nA. **The pair of cases establishes a double dissociation between social cognition and episodic memory, supporting relative independence of these functions and suggesting that Patient X’s primary pathology lies in frontotemporal salience and semantic appraisal networks rather than the hippocampal formation.**\nThis statement accurately reflects the analysis. The two patient profiles perfectly fit the definition of a double dissociation. The logical consequence, as stated in the problem's premises, is the relative independence of the functions. Furthermore, Patient X's pattern of impaired social cognition with preserved memory, combined with MRI findings of frontotemporal atrophy and normal hippocampi, strongly points to a primary pathology in the frontotemporal networks.\n**Verdict: Correct.**\n\nB. **The data rule out any contribution of the hippocampal formation to social cognition in healthy adults.**\nThis is an overstatement and an invalid inference. The cohort data show a near-zero partial correlation ($r_{p}(V_{\\text{HIP}}, z_{\\text{ToM}})=+0.08$) in a cohort of patients with degenerative etiologies. Absence of evidence for a linear correlation in a patient group does not constitute proof of absence of any contribution in healthy adults. The hippocampus might contribute to aspects of social cognition not measured here, or through non-linear mechanisms. Scientific claims of \"ruling out any contribution\" require a much higher burden of proof than provided.\n**Verdict: Incorrect.**\n\nC. **The profile in Patient X is most parsimoniously explained by a single-domain attentional deficit; since attention $z$-scores are near normal, the deficits likely reflect general factors rather than distinct neural systems.**\nThis statement is internally contradictory and factually wrong based on the provided data. It proposes an attentional deficit as the explanation but immediately notes that attention scores ($z_{\\text{DSF}}=0.0$, $z_{\\text{DSB}}=-0.4$) are normal. An explanation that is contradicted by the evidence is not parsimonious. The claim that the deficits reflect \"general factors\" is also directly opposite to the evidence; the highly specific pattern of deficits (impaired social cognition, spared memory) is a hallmark of a process affecting a distinct neural system, not a general one.\n**Verdict: Incorrect.**\n\nD. **The complementary anatomical and behavioral pattern across patients, together with independent volume–performance associations in the cohort, support network-level localization: anterior insula and orbitofrontal cortex for social cognition and hippocampal formation for episodic memory.**\nThis statement provides an excellent synthesis of all available evidence. It correctly identifies the \"complementary anatomical and behavioral pattern\" (the double dissociation) in the two patients. It also correctly incorporates the \"independent volume-performance associations\" from the cohort study, which reinforce the specificity of the findings. The conclusion drawn—that these data support a specific network-level localization for the two functions—is the most robust and comprehensive conclusion possible from the provided information.\n**Verdict: Correct.**\n\nE. **The intact episodic memory in Patient X proves that behavioral variant Frontotemporal Dementia (bvFTD) never impairs episodic memory at any disease stage.**\nThis is a gross overgeneralization from a single case. Patient X represents one individual, likely at a particular (and probably early) stage of their disease. It is a logical fallacy to conclude that because this one patient has intact memory, no patient with this condition will ever develop memory impairment at any point. In fact, it is clinically well-established that as bvFTD progresses, pathology can spread, and other cognitive domains, including memory, can become impaired. A single data point cannot prove a universal negative.\n**Verdict: Incorrect.**",
            "answer": "$$\\boxed{AD}$$"
        }
    ]
}